+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alpha 1 Agonist"

Alpha-1 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha-1 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Alpha 1 agonists are a class of drugs used in oncology to treat a variety of cancers. These drugs work by targeting and blocking the activity of the alpha 1 receptor, which is a protein found on the surface of cancer cells. This helps to reduce the growth and spread of cancer cells. Alpha 1 agonists are typically used in combination with other cancer treatments, such as chemotherapy and radiation therapy. They can also be used to reduce the side effects of other treatments. Alpha 1 agonists are used to treat a variety of cancers, including breast, lung, and prostate cancer. They are also used to treat certain types of leukemia and lymphoma. These drugs are generally well-tolerated and have few side effects. The Alpha 1 agonist market is a rapidly growing sector of the oncology drug market. Companies such as AstraZeneca, Bristol-Myers Squibb, and Pfizer are leading the way in developing and marketing these drugs. Other companies such as Merck, Novartis, and Roche are also active in the market. Show Less Read more